CDCharan Kaur Dardi

Charan Kaur Dardi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Charan Kaur Dardi has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Aastha Pandey

    Department of Community Medicine, MIMER Medical College, Talegaon Dabhade, Pune, India

    1 shared publication
  • Pandey Narayan

    Department of Community Medicine, MIMER Medical College, Talegaon Dabhade, Pune, Maharashtra, India

    1 shared publication
  • S. Maral Sanjivani

    Symbiosis Institute of Health Sciences

    1 shared publication
  • Sadhana Sanjay Chate

    Department of Microbiology, Maharashtra Institute of Medical Education and Research Medical College, Talegaon, Dabhade, Pune, Maharashtra, India

    1 shared publication

Latest Publications

  • Open Access

    KAP study on bio-medical waste management among interns in a tertiary care hospital in Maharashtra

    by Aastha Pandey, Charan Kaur Dardi

    Background: Biomedical Waste Management is Hazardous and can lead to many infections and diseases. Interns are the future physicians of tomorrow and they should be conscious about safe disposal and segregation practices. So, the present study was undertaken to assess the knowledge and awareness about Biomedical waste management in Interns. The aims and objectives were to assess the knowledge and awareness about biomedical waste management in Interns. Methods: This cross sectional study was carried out in 51 interns. A pretested self-administered questionnaire on BMW management was given to the interns. Results: Out of 51 interns 26 were girls and 25 were boys. 63% knew correct definition of biomedical waste. 23.5% said that authorization is required by CPCB. 15% had undergone training but 60% were keen to attend training programme. 86% had correct knowledge about sources of generation of BMW and 94% had knowledge of Biohazard symbol. Only 68% had knowledge of segregation of waste but none had knowledge of correct colour coding. 88% answered that record maintenance was essential for biomedical waste management. 94% said that BMW is teamwork. Conclusions: There is a need for rigorous training programme for interns and monitoring is needed.


  • Open Access

    Study of antibiotic resistance pattern in methicillin resistant staphylococcus aureus with special reference to newer antibiotic

    by Dardi Charan Kaur, Sadhana Sanjay Chate

    The worldwide epidemic of antibiotic resistance is in danger of ending the golden age of antibiotic therapy. Resistance impacts on all areas of medicine, and is making successful empirical therapy much more difficult to achieve. Staphylococcus aureus demonstrates a unique ability to quickly respond to each new antibiotic with the development of a resistance mechanism, starting with penicillin,until the most recent, linezolid and daptomycin. Methicillin resistant S. aureus (MRSA) has become endemic today in hospitals worldwide. Resistance to the newer antimicrobial-agents - linezolid, vancomycin, teicoplanin, and daptomycin are been reported and also the fear of pandrug-resistance. This study was carried out to know the antimicrobial resistant pattern of MRSA to newer antibiotic, to know any isolates are extensively-drug resistant (XDR)/pandrug resistant (PDR), inducible macrolide-lincosamide streptogramin B (iMLSB), and mupirocin resistance. Thirty-six MRSA isolates resistant to the routinely tested antibiotic were further tested for list of antibiotic by a group of international experts. Isolates were tested for iMLSB and mupirocin resistance by the disk diffusion method. Of 385 MRSA, 36 (9.35%) isolates of MRSA were resistant to the routinely tested antibiotic. Among these 36 MRSA isolates, none of our isolates were XDR/PDR or showed resistant to anti-MRSA cephalosporins (ceftaroline), phosphonic acids, glycopeptides, glycylcyclines, and fucidanes. Lower resistance was seen in oxazolidinones (2.78%), streptogramins (5.56%), lipopeptide (5.56%). Thirty-four (94.44%) isolates showed constitutive MLSB (cMLSB) resistance and two (5.56%) iMLSB phenotypes. High- and low-level mupirocin resistance were seen in 13 (36.11%) and six (16.67%), respectively. In our study, none of our isolates were XDR or PDR. No resistance was observed to ceftaroline, telavancin, teicoplanin, and vancomycin; but the presence of linezolid resistance (1, 2.28%) and daptomycin resistance (2, 5.56%) in our rural set-up is a cause of concern.


  • Open Access

    Biofilm formation and antimicrobial resistance pattern among uropathogens

    by G Dardi Charan Kaur, S. Maral Sanjivani

    Background Bacterial biofilms play an important role in urinary tract infections and is responsible for persistence infections and also the higher antimicrobial resistance is seen in biofilm forming uropathogen as compared to free floating bacteria. So the present study was undertaken with the aim to know the prevalence of biofilm formation and antimicrobial resistant pattern of biofilm producer and non-biofilm producing uropathogens. Materials & Methods A total of 146 Gram negative bacilli and 62 S. aureus isolated from patients suspected UTIs were tested for biofilm formation and antimicrobial susceptibility testing by Kirby-Bauer disc diffusion method on Mueller Hinton agar as per CLSI guidelines. Result Out of 208 isolates from urine, Biofilm formation was noted in 122(58.66%) and no biofilm formation in 86(41.35%). [Strong Biofilm formation in 76(36.54%) and weak biofilm formation in 46(22.12%). In our study, we noted biofilm and non-biofilm forming microorganism showed mark difference in antimicrobial resistance pattern. In Staphylococcus aureus striking difference was noted to ciprofloxacin (100% versus 33.33%) and azithromycin (96%versus 41.67%). Isolates showed no resistance to linezolid. Whereas isolates of Pseudomonas aeruginosa to netilin (100% versus 42.86%).And in other Gram negative bacilli difference was noted to gentamicin (87.93% versus 13.43%) and norfloxacin (84.48% versus 37.31%) Conclusion Biofilm forming isolates showed higher antimicrobial resistance as compared to non-biofilm producer. Thus, Uropathogen should be routinely screened for biofilm formation.


  • Open Access

    Mupirocin resistance in nasal carriage ofStaphylococcus aureusamong healthcare workers of a tertiary care rural hospital

    by Dardi Kaur, Pandey Narayan

    Mupirocin (pseudomonic acid A) is a topical antimicrobial agent with excellent antistaphylococcal and antistreptococcal activity. A nasal formulation is approved by the United States Food and Drug Administration for eradicating nasal carriage in adult patients as well as in health care personnel. Resistance to mupirocin has already been reported worldwide. The increasing prevalence of mupirocin resistance among Staphylococcus aureus and coagulase-negative Staphylococcus (CoNS) species could be an important threat to the future use of mupirocin against methicillin-resistant S. aureus (MRSA). Thus, this study was carried out to find the prevalence of mupirocin resistance in S. aureus and CoNS by disc diffusion and to determine the rates of high-level and low-level mupirocin resistance in S. aureus and CoNS by disc diffusion. A total of 140 healthcare workers (HCWs) (doctor, nursing staff, housekeeping staff) were randomly selected. S. aureus and CoNS isolates were tested for mupirocin resistance by the disk diffusion method using 5 μg and 200 μg mupirocin discs. MRSA isolates were tested for antibiotics by Kirby-Bauer disc-diffusion method as per Clinical and Laboratory Standards Institute guidelines. Out of 140 nasal swabs collected from HCWs, S. aureus was isolated in 38 (27.14%), and CoNS was isolated in 73 (52.14%). MRSA was isolated in 20 (14.28%) and methicillin-resistant coagulase-negative Staphylococci (MRCoNS) in 34 (24.29%. Methicillin-sensitive S. aureus (MSSA) and MSCoNS isolates were 100% sensitive to mupirocin, but two isolates from MRSA (1.43%) and five from MRCoNS (3.57%) were mupirocin resistant. The presence of mupirocin resistance in MRSA and MRCoNS is a cause for concern. It could be limited by regular surveillance and effective infection control initiatives so to inform health care facilities to guide therapeutic and prophylactic use of mupirocin.